Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01094782 · ClinicalTrials.gov registry record · NA

Evaluating the Effect of Acupuncture on Pain Relief Using Quantitative Sensory Testing (QST)

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
254
Enrollment target

NCT01094782: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01094782 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 254 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01094782, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
254 participants
Enrollment target

Study Summary

The purpose of this study is to explore a new approach in assessing the effectiveness of acupuncture therapy in the treatment chronic pain conditions.

Primary Outcome

Changes in response to heat stimulation stated as tolerance to heat. Responses are measured with a quantitative sensory testing (QST) device. Measurements were taken before the course of a 4 week acupuncture treatment schedule.

Interventions

  • OTHER Acupuncture
  • OTHER Sham Acupuncture

Trial Details

FieldValue
Enrollment Target 254 participants
Start Date 2010-01
Est. Completion 2021-12-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01094782 record still lists

NCT01094782 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 2 interventions - of which Acupuncture is the first listed.

NCT01094782 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01094782 about?

NCT01094782 is a clinical study titled "Evaluating the Effect of Acupuncture on Pain Relief Using Quantitative Sensory Testing (QST)". The purpose of this study is to explore a new approach in assessing the effectiveness of acupuncture therapy in the treatment chronic pain conditions.

What is the current status of trial NCT01094782?

This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2010-01. Estimated completion is 2021-12-01.

What interventions are being tested in trial NCT01094782?

The interventions under investigation include: Acupuncture (OTHER), Sham Acupuncture (OTHER).

Who is sponsoring clinical trial NCT01094782?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01094782's enrollment target sits among peer trials

254 407th of 2000 higher than 1,594 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04390737 · 254 participants · Phase 1

    Evaluate the Safety and Clinical Activity of HH2853

  • NCT04677647 · 254 participants · NA

    OurChild: A Health IT Solution to Reduce Minority Health Disparities

  • NCT05503797 · 254 participants · Phase 2

    A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • NCT06167317 · 254 participants · Phase 1

    Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01094782, the US trial registry maintained by the National Library of Medicine. NCT01094782 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.